Cutaneous reactions to interferon and ribavirin [3]

Internal Medicine Journal

Volumn 34, Issue 8, 2004, Pages 519-

  Chamberlain, A J ^a   Poon, E ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; RIBAVIRIN;

CLINICAL TRIAL; DRUG ERUPTION; ECZEMA; HEPATITIS C; HUMAN; LETTER; LICHENOID ERUPTION; PALLIATIVE THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PRURITUS; PSORIASIS; XEROSIS;

ANTIVIRAL AGENTS; DERMATOLOGIC AGENTS; DRUG ERUPTIONS; DRUG THERAPY, COMBINATION; HEPATITIS C, CHRONIC; INTERFERON ALFA-2B; RIBAVIRIN;

EID: 19344362747     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2004.00660.x     Document Type: Letter

References (4)

1. Kontorinis N, Garas G, Young J, Speers D, Chester BP, MacQuillin GC et al. Outcome, tolerability and compliance of compassionate use interferon and ribavirin for hepatitis C infection in a shared care hospital clinic. Intern Med J 2003; 33: 500-4.
2. Kerl K, Negro F, Lubbe J. Cutaneous side effects of treatment of chronic hepatitis C by interferon alpha and ribavirin. Br J Dermatol 2003; 149: 656.
3. Dereure O, Raison-Peyron N, Larrey D, Blanc F, Guilhou JJ. Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C. a series of 20 patients. Br J Dermatol 2002; 147: 1142-6.
4. Sookoian S, Neglia V, Castano G, Frider B, Kien MC, Chohuela E. High prevalence of reactions to interferon alpha plus ribavirin combination therapy in patients with chronic hepatitis C virus. Arch Dermatol 1999; 135: 1000-1.